CN103892282A - Protein meal with function of promoting bone growth and preparation method of protein meal - Google Patents
Protein meal with function of promoting bone growth and preparation method of protein meal Download PDFInfo
- Publication number
- CN103892282A CN103892282A CN201410160964.2A CN201410160964A CN103892282A CN 103892282 A CN103892282 A CN 103892282A CN 201410160964 A CN201410160964 A CN 201410160964A CN 103892282 A CN103892282 A CN 103892282A
- Authority
- CN
- China
- Prior art keywords
- powder
- lactoferrin
- bone growth
- albumen powder
- promotes bone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 27
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 27
- 230000008468 bone growth Effects 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 230000001737 promoting effect Effects 0.000 title abstract description 8
- 235000012054 meals Nutrition 0.000 title abstract 8
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims abstract description 61
- 108010063045 Lactoferrin Proteins 0.000 claims abstract description 59
- 102000010445 Lactoferrin Human genes 0.000 claims abstract description 58
- 235000021242 lactoferrin Nutrition 0.000 claims abstract description 58
- 229940078795 lactoferrin Drugs 0.000 claims abstract description 58
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 52
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 25
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 25
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 25
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 25
- 235000018102 proteins Nutrition 0.000 claims abstract description 25
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 25
- 239000011709 vitamin E Substances 0.000 claims abstract description 25
- 229940046009 vitamin E Drugs 0.000 claims abstract description 25
- 238000000034 method Methods 0.000 claims abstract description 18
- 238000005277 cation exchange chromatography Methods 0.000 claims abstract description 8
- 238000001035 drying Methods 0.000 claims abstract description 8
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims abstract description 6
- 238000002156 mixing Methods 0.000 claims abstract description 5
- 229910000019 calcium carbonate Inorganic materials 0.000 claims abstract description 3
- 239000002994 raw material Substances 0.000 claims abstract description 3
- 239000000843 powder Substances 0.000 claims description 63
- 239000007788 liquid Substances 0.000 claims description 38
- 239000005862 Whey Substances 0.000 claims description 24
- 239000000047 product Substances 0.000 claims description 13
- 238000010828 elution Methods 0.000 claims description 12
- 235000013336 milk Nutrition 0.000 claims description 12
- 210000004080 milk Anatomy 0.000 claims description 12
- 239000008267 milk Substances 0.000 claims description 12
- 230000008569 process Effects 0.000 claims description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 10
- 238000005374 membrane filtration Methods 0.000 claims description 10
- 239000000243 solution Substances 0.000 claims description 10
- 102000004407 Lactalbumin Human genes 0.000 claims description 9
- 108090000942 Lactalbumin Proteins 0.000 claims description 9
- 239000011259 mixed solution Substances 0.000 claims description 8
- 238000010926 purge Methods 0.000 claims description 8
- 238000000108 ultra-filtration Methods 0.000 claims description 8
- 239000011324 bead Substances 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 239000007853 buffer solution Substances 0.000 claims description 6
- 238000005238 degreasing Methods 0.000 claims description 6
- 239000003480 eluent Substances 0.000 claims description 6
- 230000007717 exclusion Effects 0.000 claims description 6
- 238000012437 strong cation exchange chromatography Methods 0.000 claims description 6
- 238000002305 strong-anion-exchange chromatography Methods 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 235000020183 skimmed milk Nutrition 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- 229920002684 Sepharose Polymers 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 21
- 238000000746 purification Methods 0.000 abstract description 4
- 235000010216 calcium carbonate Nutrition 0.000 abstract description 2
- 230000004663 cell proliferation Effects 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 230000011164 ossification Effects 0.000 abstract description 2
- 210000002449 bone cell Anatomy 0.000 abstract 1
- 238000001542 size-exclusion chromatography Methods 0.000 abstract 1
- 235000021119 whey protein Nutrition 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 description 16
- 230000006870 function Effects 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- 210000000963 osteoblast Anatomy 0.000 description 11
- 238000012856 packing Methods 0.000 description 10
- 210000002997 osteoclast Anatomy 0.000 description 9
- 239000000523 sample Substances 0.000 description 9
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- 230000033228 biological regulation Effects 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 210000000988 bone and bone Anatomy 0.000 description 6
- 239000011575 calcium Substances 0.000 description 6
- 229910052791 calcium Inorganic materials 0.000 description 6
- 241000700159 Rattus Species 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 230000037180 bone health Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 230000001582 osteoblastic effect Effects 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 208000001132 Osteoporosis Diseases 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000014461 bone development Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 229940011871 estrogen Drugs 0.000 description 3
- 239000000262 estrogen Substances 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000009777 vacuum freeze-drying Methods 0.000 description 3
- 238000012356 Product development Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 108010038047 apolactoferrin Proteins 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000002146 bilateral effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000004097 bone metabolism Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 235000020247 cow milk Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 235000020256 human milk Nutrition 0.000 description 2
- 210000004251 human milk Anatomy 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 235000020185 raw untreated milk Nutrition 0.000 description 2
- 230000019491 signal transduction Effects 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 210000000689 upper leg Anatomy 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 241000282828 Camelus bactrianus Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 102000008857 Ferritin Human genes 0.000 description 1
- 108050000784 Ferritin Proteins 0.000 description 1
- 238000008416 Ferritin Methods 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 108010023244 Lactoperoxidase Proteins 0.000 description 1
- 102000045576 Lactoperoxidases Human genes 0.000 description 1
- 102000012174 Lactotransferrin Human genes 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 102000019259 Succinate Dehydrogenase Human genes 0.000 description 1
- 108010012901 Succinate Dehydrogenase Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 241000256856 Vespidae Species 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 230000006851 antioxidant defense Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 235000020248 camel milk Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 244000144993 groups of animals Species 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000004957 immunoregulator effect Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 229940057428 lactoperoxidase Drugs 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000014059 processed cheese Nutrition 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- -1 salt ion Chemical class 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000011265 semifinished product Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A23L33/165—Complexes or chelates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410160964.2A CN103892282B (en) | 2014-04-21 | 2014-04-21 | A kind of have albumen powder promoting bone growth function and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410160964.2A CN103892282B (en) | 2014-04-21 | 2014-04-21 | A kind of have albumen powder promoting bone growth function and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103892282A true CN103892282A (en) | 2014-07-02 |
CN103892282B CN103892282B (en) | 2016-03-16 |
Family
ID=50984111
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410160964.2A Active CN103892282B (en) | 2014-04-21 | 2014-04-21 | A kind of have albumen powder promoting bone growth function and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103892282B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106072670A (en) * | 2016-06-13 | 2016-11-09 | 合肥赛为智慧医疗有限公司 | A kind of salt alga is combined Bovine Lactoferrin powder and preparation method thereof |
CN109527595A (en) * | 2018-10-31 | 2019-03-29 | 浙江中医药大学 | A kind of product rich in lactalbumin polypeptide and preparation method thereof, application |
CN112655768A (en) * | 2020-12-16 | 2021-04-16 | 黑龙江飞鹤乳业有限公司 | Preparation method of milk powder containing lactoferrin |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09107917A (en) * | 1995-10-17 | 1997-04-28 | Snow Brand Milk Prod Co Ltd | Low cariogenic nutritive composition |
CN101536787A (en) * | 2009-05-04 | 2009-09-23 | 北京康比特体育科技股份有限公司 | Sugar-free high-calcium albumen powder for improving senile osteoporosis |
CN102613559A (en) * | 2012-04-11 | 2012-08-01 | 江苏四环生物制药有限公司 | Composite protein powder capsule and preparation method thereof |
CN103110117A (en) * | 2013-01-31 | 2013-05-22 | 南昌朗臣实业有限公司 | Compound protein powder and preparation method thereof |
-
2014
- 2014-04-21 CN CN201410160964.2A patent/CN103892282B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09107917A (en) * | 1995-10-17 | 1997-04-28 | Snow Brand Milk Prod Co Ltd | Low cariogenic nutritive composition |
CN101536787A (en) * | 2009-05-04 | 2009-09-23 | 北京康比特体育科技股份有限公司 | Sugar-free high-calcium albumen powder for improving senile osteoporosis |
CN102613559A (en) * | 2012-04-11 | 2012-08-01 | 江苏四环生物制药有限公司 | Composite protein powder capsule and preparation method thereof |
CN103110117A (en) * | 2013-01-31 | 2013-05-22 | 南昌朗臣实业有限公司 | Compound protein powder and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
刘猛,等: "牛乳乳铁蛋白的纯化及热处理对其分子特性的影响", 《食品科学技术学报》, vol. 31, no. 2, 30 April 2013 (2013-04-30), pages 26 - 30 * |
曹阳,等: "乳铁蛋白研究现状", 《食品科学》, vol. 23, no. 12, 31 December 2002 (2002-12-31), pages 132 - 138 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106072670A (en) * | 2016-06-13 | 2016-11-09 | 合肥赛为智慧医疗有限公司 | A kind of salt alga is combined Bovine Lactoferrin powder and preparation method thereof |
CN109527595A (en) * | 2018-10-31 | 2019-03-29 | 浙江中医药大学 | A kind of product rich in lactalbumin polypeptide and preparation method thereof, application |
CN112655768A (en) * | 2020-12-16 | 2021-04-16 | 黑龙江飞鹤乳业有限公司 | Preparation method of milk powder containing lactoferrin |
Also Published As
Publication number | Publication date |
---|---|
CN103892282B (en) | 2016-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2008512398A (en) | Human milk fortifier and its manufacturing method | |
CN104798908A (en) | Zinc-rich formula goat milk powder and preparation method thereof | |
CN103892282B (en) | A kind of have albumen powder promoting bone growth function and preparation method thereof | |
CN103636798B (en) | A kind of preparation method of cow-goat milk mixed-type infant formula milk powder | |
EP3917338A1 (en) | Native whey protein for improving intestinal maturation | |
US20170348399A1 (en) | Novel protein material | |
Çelik | Whey every aspect | |
CN1260248C (en) | Active lactoprotein extracted from yak milk and its extraction method and use | |
Mahami et al. | Preliminary study on the influence of moringa seed extracts supplementation on the yield and quality of cottage cheese | |
WO2013132675A1 (en) | Bone-strengthening agent | |
CN105638907A (en) | Infant formula milk powder capable of improving immunity | |
CN101248819B (en) | Preparation of IgG riched-containing bovine colostrum | |
CN104798888A (en) | High-calcium goat milk powder and preparation method thereof | |
CN105767997A (en) | Bee pollen and preparation method thereof | |
CN104939098A (en) | Health food capable of enhancing bone immunity and supplementing and locking calcium and preparation method of health food | |
CN102293334B (en) | Improved sterile artificial rat feeding milk | |
Pamarthy et al. | A comparative study on Casein and Albumin contents in cow and commercial milk samples | |
CN101868475A (en) | Food material for inhibiting bone resorption | |
CN109010367A (en) | Bovine colostrum and preparation method thereof, preparation and the application in preparation tumor | |
US20190091304A1 (en) | Novel protein material | |
FATMA et al. | SDS-PAGE protein profile of albumin extracted by steaming from four marine and three brackish-water fishes | |
JP6357265B2 (en) | Protein material for bone disease prevention or treatment | |
CN106538691A (en) | A kind of milk product | |
Mishra | Chapter-8 Chemistry, Applications and Health Benefits of Donkey Milk: A Review | |
Mishra et al. | Chemistry, Applications and Health Benefits of Donkey Milk: A Review |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20181102 Address after: 253200 No. 14, Nan Tun Zi street, Xiajin County, Dezhou, Shandong Patentee after: Wang Meng Address before: 150000 No. 92, West Da Zhi street, Nangang District, Harbin, Heilongjiang. Patentee before: Harbin Institute of Technology |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240506 Address after: Room 208, Building 21, No. 1, Lane 350, Yanjiang Road, Xidu Street, Fengxian District, Shanghai, January 2014 Patentee after: Shanghai Aiston Medical Technology Co.,Ltd. Country or region after: China Address before: 253200 No. 14, Nan Tun Zi street, Xiajin County, Dezhou, Shandong Patentee before: Wang Meng Country or region before: China |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240628 Address after: Room G1-0574, Unit 311, Zone B, 3rd Floor, No. 85 Zhongshan 1st Road, Yuzhong District, Chongqing, 400010 Patentee after: Chongqing Baai Biotechnology Co.,Ltd. Country or region after: China Address before: Room 208, Building 21, No. 1, Lane 350, Yanjiang Road, Xidu Street, Fengxian District, Shanghai, January 2014 Patentee before: Shanghai Aiston Medical Technology Co.,Ltd. Country or region before: China |